CAMP4 Therapeutics Corpor... (CAMP)
NASDAQ: CAMP
· Real-Time Price · USD
2.17
0.03 (1.40%)
At close: May 09, 2025, 3:59 PM
2.13
-1.84%
After-hours: May 09, 2025, 05:47 PM EDT
CAMP4 Therapeutics Revenue Breakdown
| Period Ending | Feb 28, 2023 | Feb 28, 2022 | Feb 28, 2021 | Feb 28, 2019 |
|---|---|---|---|---|
| Application Subscriptions And Other Services Revenue | 106.07M | 112.92M | 115.1M | 285.88M |
| Application Subscriptions And Other Services Revenue Growth | -6.07% | -1.89% | -59.74% | n/a |
| Product Revenue | 188.88M | 182.92M | 193.49M | n/a |
| Product Revenue Growth | +3.26% | -5.46% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 | May 31, 2018 | Feb 28, 2018 | Nov 30, 2017 | Aug 31, 2017 | May 31, 2017 | Feb 28, 2017 | Nov 30, 2016 | Aug 31, 2016 | May 31, 2016 | Feb 29, 2016 | Nov 30, 2015 | Aug 31, 2015 | May 31, 2015 | Feb 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 19M | 19.63M | 22.38M | 22.65M | 23.66M | 26.26M | 26.64M | 24.49M | 26.01M | 25.25M | 25.15M | 25.63M | 28.29M | 27.39M | 26.55M | 28.34M | 28.97M | 28.76M | 32.13M | 6.05M | 24.46M | 24.51M | 25.93M | 25.86M | 23.97M | 23.27M | 29.08M | 29.52M | 24.17M | 23.97M | 27.29M | 16.24M | 11.18M | 10.76M | 10.27M | 9.23M |
| Selling, General, and Administrative Revenue Growth | -3.23% | -12.27% | -1.19% | -4.28% | -9.92% | -1.41% | +8.78% | -5.86% | +3.05% | +0.39% | -1.89% | -9.39% | +3.27% | +3.15% | -6.32% | -2.14% | +0.71% | -10.49% | +431.09% | -75.27% | -0.20% | -5.47% | +0.29% | +7.86% | +3.02% | -19.98% | -1.48% | +22.12% | +0.85% | -12.18% | +68.05% | +45.30% | +3.92% | +4.69% | +11.29% | n/a |
| Research and Development Revenue | 4.05M | 4.8M | 5.84M | 5.33M | 5.48M | 6.76M | 7M | 6.6M | 7.18M | 7.73M | 6.94M | 6.89M | 6.78M | 6.99M | 6.32M | 6.88M | 7.74M | 7.92M | 6.89M | 6.28M | 7.18M | 7.6M | 6.6M | 6.91M | 6.3M | 6.72M | 5.83M | 4.73M | 5.3M | 5.88M | 6.09M | 5.12M | 5.12M | 5M | 4.57M | 4.87M |
| Research and Development Revenue Growth | -15.60% | -17.84% | +9.52% | -2.65% | -18.91% | -3.47% | +6.12% | -8.12% | -7.12% | +11.37% | +0.78% | +1.52% | -2.95% | +10.52% | -8.13% | -11.08% | -2.30% | +15.07% | +9.67% | -12.51% | -5.55% | +15.12% | -4.44% | +9.72% | -6.38% | +15.31% | +23.25% | -10.67% | -9.99% | -3.38% | +18.92% | +0.02% | +2.52% | +9.42% | -6.22% | n/a |
| Sales and Marketing Revenue | 8.88M | 9.62M | 11.02M | 10.69M | 12.49M | 12.73M | 11.48M | 10.82M | 13.24M | 12.05M | 12.46M | 12.46M | 14.65M | 13.49M | 12.89M | 15.34M | 14.68M | 15.87M | 14.65M | 12.13M | 12.75M | 12.52M | 12.5M | 11.93M | 12.98M | 12.52M | 12.67M | 12.23M | 12.82M | 12.68M | 11.31M | 6.06M | 5.97M | 5.85M | 5.5M | 5.18M |
| Sales and Marketing Revenue Growth | -7.63% | -12.75% | +3.11% | -14.38% | -1.95% | +10.94% | +6.12% | -18.30% | +9.89% | -3.33% | +0.02% | -14.94% | +8.55% | +4.71% | -15.98% | +4.45% | -7.47% | +8.34% | +20.79% | -4.86% | +1.78% | +0.21% | +4.76% | -8.10% | +3.72% | -1.23% | +3.56% | -4.55% | +1.06% | +12.16% | +86.60% | +1.42% | +2.19% | +6.35% | +6.10% | n/a |